NIVEGU.KNOW BEFORE YOU FLY

THE WORLD OF AVIATION.
YOUR JOURNEY, EXPLAINED.

Search Plan my trip
NASDAQ / LIVE COMPANY INTELLIGENCE

FibroBiologics, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERFBLG
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / FBLG COVERAGE

What’s moving FibroBiologics, Inc. now

Current reporting with the operating signal separated from the noise.

01
Yahoo! Finance Canada

FibroBiologics, Inc. (FBLG) Stock Price, News, Quote & History

Investors are testing whether FibroBiologics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
02
FibroBiologics, Inc.: FibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage

FibroBiologics, Inc.: FibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage

The story matters when it changes FibroBiologics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
FibroBiologics, Inc. Announces Investor Webinar on Innovative Fibroblast-Based Cell Therapy Platform

FibroBiologics, Inc. Announces Investor Webinar on Innovative Fibroblast-Based Cell Therapy Platform

The story matters when it changes FibroBiologics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
FibroBiologics, Inc. to Host Analyst Day on Fibroblast-Based Therapeutics in New York on February 12, 2025

FibroBiologics, Inc. to Host Analyst Day on Fibroblast-Based Therapeutics in New York on February 12, 2025

The story matters when it changes FibroBiologics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest FBLG filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-07-31 · Period 2026-06-30SEC ↗10-QQuarterly financial reportFiled 2026-04-30 · Period 2026-03-31SEC ↗10-K/AAnnual financial reportFiled 2026-03-13 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-09-18 · Period 2026-09-17SEC ↗8-KMaterial company eventFiled 2026-09-15 · Period 2026-09-15SEC ↗8-KMaterial company eventFiled 2026-08-24 · Period 2026-08-20SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-07-31 · Period 2026-09-17SEC ↗SCHEDULE 13DOfficial SEC filingFiled 2026-09-17SEC ↗
EARNINGS / QUARTERLY TRACKER

FibroBiologics, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.